Definitive Healthcare (DH) Stock Price, News & Analysis

Definitive Healthcare logo
$1.21 -0.13 (-9.70%)
Closing price 04:00 PM Eastern
Extended Trading
$1.21 0.00 (0.00%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Definitive Healthcare Stock (NASDAQ:DH)

Advanced

Key Stats

Today's Range
$1.19
▼
$1.42
50-Day Range
$0.89
▼
$1.34
52-Week Range
$0.61
▼
$3.00
Volume
566,809 shs
Average Volume
448,301 shs
Market Capitalization
$129.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.47
Consensus Rating
Reduce

Company Overview

Definitive Healthcare provides data and analytics software for organizations across the healthcare industry. Its platform brings together information on healthcare providers, facilities, services and market activity to help customers understand the healthcare landscape and make business decisions.

The company serves customers including life sciences and medical technology companies, healthcare providers, health plans and consulting firms. Its tools support activities such as identifying and evaluating healthcare professionals and organizations, assessing markets, planning sales and marketing efforts, and analyzing provider networks.

Founded in 2011, Definitive Healthcare focuses primarily on the U.S. healthcare market. The company went public in 2021, and its platform has developed through both internal product development and acquisitions.

AI Generated. May Contain Errors.

Definitive Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

DH MarketRank™: 
2.8387228817 of 5 stars

Definitive Healthcare scored higher than 57% of companies evaluated by MarketBeat, and ranked 1349th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Definitive Healthcare has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 6 hold ratings, and 3 sell ratings.

  • Upside Potential

    Definitive Healthcare has a consensus price target of $1.47, representing about 21.6% upside from its current price of $1.21.

  • Amount of Analyst Coverage

    Definitive Healthcare has only been the subject of 2 research reports in the past 90 days.

  • Read more about Definitive Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Definitive Healthcare are expected to decrease by -33.33% in the coming year, from $0.06 to $0.04 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Definitive Healthcare is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Definitive Healthcare is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Definitive Healthcare has a PEG Ratio of 16.17. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Definitive Healthcare has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.82% of the float of Definitive Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Definitive Healthcare has a short interest ratio ("days to cover") of 3.82, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Definitive Healthcare has recently decreased by 16.01%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Definitive Healthcare does not currently pay a dividend.

  • Dividend Growth

    Definitive Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Definitive Healthcare has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Definitive Healthcare this week, compared to 2 articles on an average week.
  • Search Interest

    5 people have searched for DH on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Definitive Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.09% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Definitive Healthcare's insider trading history.
Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DH Stock News Headlines

Definitive Healthcare Announces AI-Powered Growth Intelligence Platform
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
See More Headlines

DH Stock Analysis - Frequently Asked Questions

Definitive Healthcare's stock was trading at $2.87 at the start of the year. Since then, DH stock has decreased by 57.8% and is now trading at $1.21.

Definitive Healthcare Corp. (NASDAQ:DH) released its earnings results on Thursday, November, 5th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. The company had revenue of $54.65 million for the quarter, compared to analyst estimates of $54.58 million. Definitive Healthcare had a positive trailing twelve-month return on equity of 4.35% and a negative net margin of 69.18%.

Definitive Healthcare (DH) raised $389 million in an IPO on Tuesday, September 14th 2021. The company issued 15,555,555 shares at $24.00-$26.00 per share.

Top institutional shareholders of Definitive Healthcare include Goldman Sachs Group Inc. (1.01%), State Street Corp (0.22%), Marshall Wace LLP (0.14%) and Jefferies Financial Group Inc. (0.09%).
View institutional ownership trends
.

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Definitive Healthcare investors own include AppLovin (APP), Confluent (CFLT), Palantir Technologies (PLTR), Toast (TOST), AirSculpt Technologies (AIRS), Alibaba Group (BABA) and DigitalOcean (DOCN).

Company Calendar

Last Earnings
11/05/2026
Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:DH
CIK
1861795
Fax
N/A
Employees
686
Year Founded
2011

Price Target and Rating

High Price Target
$3.00
Low Price Target
$0.70
Potential Upside/Downside
+21.6%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
30.25
P/E Growth
16.17
Net Income
-$138.93 million
Net Margins
-69.18%
Pretax Margin
-99.73%
Return on Equity
4.35%
Return on Assets
1.84%

Debt

Debt-to-Equity Ratio
0.79
Current Ratio
1.96
Quick Ratio
1.96

Sales & Book Value

Annual Sales
$227.31 million
Price / Sales
0.57
Cash Flow
$1.83 per share
Price / Cash Flow
0.66
Book Value
$1.76 per share
Price / Book
0.69

Miscellaneous

Outstanding Shares
107,163,000
Free Float
88,849,000
Market Cap
$129.67 million
Optionable
Optionable
Beta
1.40

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:DH) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners